Back to Search
ROSE DELVA, MD/MSN/FNP/APRN
MD/MSN/FNP/APRN
Family Nurse Practitioner
NPI: 1346786142Individual
Specialties, Licenses & Credentials
Family Nurse PractitionerPrimary
Nurse Practitioner — Family
Code: 363LF0000X
1699162(FL)
Research & Publications (20)
Randomized study of intravenous versus subcutaneous interleukin-2, and IFNalpha in patients with good prognosis metastatic renal cancer.
PMID 18794104·Clin Cancer Res·2008
4-observational
Individual fluorouracil dose adjustment based on pharmacokinetic follow-up compared with conventional dosage: results of a multicenter randomized trial of patients with metastatic colorectal cancer.
PMID 18445839·J Clin Oncol·2008
3-trial
First-line bevacizumab combined with reduced dose interferon-alpha2a is active in patients with metastatic renal cell carcinoma.
PMID 18408224·Ann Oncol·2008
3-trial
Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
PMID 18202419·J Clin Oncol·2008
4-observational
Carboplatin/cyclophosphamide or carboplatin/paclitaxel in elderly patients with advanced ovarian cancer? Analysis of two consecutive trials from the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens.
PMID 17082510·Ann Oncol·2007
4-observational
[Surveillance Bulletin 2007. Guidelines for clinical practice: management of patients with malignant epithelial tumors of the ovary. First line medical treatment].
PMID 18156120·Bull Cancer·2007
6-review
Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis: results of a randomized controlled trial.
PMID 17932908·Cancer·2007
2-rct
Oral vinorelbine/paclitaxel combination treatment of metastatic breast cancer: a phase I study.
PMID 17021821·Cancer Chemother Pharmacol·2007
3-trial
Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP).
PMID 17351252·Ann Oncol·2007
2-rct
Sequential addition of an anthracycline-based regimen to docetaxel as neoadjuvant chemotherapy in patients with operable breast cancer.
PMID 16942644·Clin Breast Cancer·2006
3-trial
A phase II study of a paclitaxel and oxaliplatin combination in platinum-sensitive recurrent advanced ovarian cancer patients.
PMID 16500913·Ann Oncol·2006
3-trial
Post-operative sequential high-dose chemotherapy with haematopoietic stem cell support as front-line treatment in advanced ovarian cancer: a phase II multicentre study.
PMID 16501596·Bone Marrow Transplant·2006
3-trial
A phase II study of an oxaliplatin/vinorelbine/5-fluorouracil combination in patients with anthracycline-pretreated and taxane-pretreated metastatic breast cancer.
PMID 17001180·Anticancer Drugs·2006
3-trial
High prognostic significance of residual disease after neoadjuvant chemotherapy: a retrospective study in 710 patients with operable breast cancer.
PMID 16267618·Breast Cancer Res Treat·2005
8-other
Tumor parameters, clinical and pathological responses, medical management, and survival through time on 710 operable breast cancers.
PMID 16110134·Med Oncol·2005
8-other
Pathological and clinical response of a primary chemotherapy regimen combining vinorelbine, epirubicin, and paclitaxel as neoadjuvant treatment in patients with operable breast cancer.
PMID 15821244·Oncologist·2005
3-trial
Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial.
PMID 15659420·Ann Oncol·2005
3-trial
Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-Fluorouracil and leucovorin for advanced colorectal cancer.
PMID 15217938·Clin Cancer Res·2004
8-other
A phase II study with 5-fluorouracil, folinic acid and oxaliplatin (FOLFOX-4 regimen) in patients with metastatic renal cell carcinoma.
PMID 12457028·Oncology·2003
3-trial
Subcutaneous interleukin-2 and interferon alpha in the treatment of patients with metastatic renal cell carcinoma-Less efficacy compared with intravenous interleukin-2 and interferon alpha. Results of a multicenter Phase II trial from the Groupe Français d'Immunothérapie.
PMID 12436438·Cancer·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6080 SW 180TH TER
SOUTHWEST RANCHES, FL 33331 - Phone
- (954) 865-7548
Quick Facts
- NPI
- 1346786142
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile